Factors Affecting Distant Disease-Free Survival for Primary Invasive Breast Cancer: Use of a Log-Normal Survival Model

[1]  J. Chapman,et al.  Competing risks analyses for recurrence from primary breast cancer , 1999, British Journal of Cancer.

[2]  S. Bull,et al.  neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  D. Allred,et al.  Prognostic and predictive factors in breast cancer by immunohistochemical analysis. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[4]  R. Bast,et al.  Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. , 1996, Journal of the National Cancer Institute.

[5]  W. Hanna,et al.  An improved statistical approach: can it clarify the role of new prognostic factors for breast cancer? , 1996, European journal of cancer.

[6]  W. Hanna,et al.  Alternative multivariate modelling for time to local recurrence for breast cancer patients receiving a lumpectomy alone. , 1996, Surgical oncology.

[7]  W. Hanna,et al.  An investigation of cut-points for primary breast cancer oestrogen and progesterone receptor assays , 1996, The Journal of Steroid Biochemistry and Molecular Biology.

[8]  M. Province,et al.  Proliferative rate by S‐phase measurement may affect cure of breast carcinoma , 1995, Cancer.

[9]  E Marubini,et al.  Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. , 1995, Journal of the National Cancer Institute.

[10]  G. Bonadonna,et al.  Parametric survival analysis of adjuvant therapy for stage II breast cancer , 1994, Cancer.

[11]  W. Sauerbrei,et al.  Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. , 1994, Journal of the National Cancer Institute.

[12]  J. Gamel,et al.  A model of long-term survival following adjuvant therapy for stage 2 breast cancer. , 1993, British Journal of Cancer.

[13]  J. Gamel,et al.  Assessing the impact of adjuvant therapy on cure rate for stage 2 breast carcinoma. , 1993, British Journal of Cancer.

[14]  I. Ellis,et al.  Factors influencing local recurrence after excision and radiotherapy for primary breast cancer , 1989, The British journal of surgery.

[15]  S. Pocock,et al.  Regression Models and Non‐Proportional Hazards in the Analysis of Breast Cancer Survival , 1984 .

[16]  L. Rutqvist,et al.  Is breast cancer a curable disease? A study of 14,731 women with breast cancer from the cancer registry of Norway , 1984, Cancer.

[17]  J. Berg.  The distribution of cancer deaths in time. A survey test of the lognormal model. , 1965, British Journal of Cancer.

[18]  P. Ravdin.  neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer , 1999 .

[19]  I J Christensen,et al.  Assessing genetic markers of tumour progression in the context of intratumour heterogeneity. , 1998, Cytometry.

[20]  J. Boag,et al.  Maximum Likelihood Estimates of the Proportion of Patients Cured by Cancer Therapy , 1949 .